维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Church DN"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Extended survival in women with brain metastases from HER-2 overexpressing breast cancer显示文摘	Church DN Modgil R Guglani S	2008	Am J Clin Oncol2008，31，3：	1
2	Clinical review - small cell carcinoma of the bladder显示文摘	Church DN Bahl A	2006	Cancer Treat Rev2006，32，8：	1
3	Survivin in solid tumors : rationale fordevelopment of inhibitors 显示文摘	Church DN Talbot DC	2012	Curr Oncol Rep2012，14，2：	1
4	Survivin in solid tumors: rationale for development of inhibiturs 显示文摘	Church DN Talbot DC	2012	Curt Oncol Rep2012，14，2：	1
5	Can Peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? 显示文摘	Church ill DN	1996	Sem in Dial1996，9，：	1
6	Survivin in solid tumors : rationale for development of inhibitors显示文摘	Church DN Talbot DC	2012	Curr Oncol Rep 2012 Apr2012，14，2：	1
7	Clinicalreview - small cell carcinoma of the bladder显示文摘	Church DN Bahl A	2006	Cancer Treat Rev2006，32，8：	1
8	Clinical review-small cell carcinoma of the bladder显示文摘	Church DN Bahl A	2006	Cancer Treat Rev2006，32，8：	1
9	Survivin in solid tumors: rationale for development of inhibitors显示文摘	Church DN Talbot DC	2012	Curr Oncol Rep2012，14，2：	1
10	Extended survival in women with brain metastases from HER2 overexpressing breast cancer显示文摘	Church DN Modgil R Guglani S	2008	Am J Clin Oncol2008，31，3：	1
11	Extended survival in women with brain metastases from HER2 overexpressing breast cancer显示文摘	Church DN Modgil R Guglani S	2008	Am J Clin Oncol2008，31，3：	1
12	Survivin in solid tumors: rationale fnr development of inhibitors显示文摘	Church DN Talbot DC	2012	Curr Oncol Rep2012，14，2：	1
13	Clinical review-small cellcarcinoma of the bladder显示文摘	Church DN Bahl A	2006	Cancer Treat Rev2006，32，8：	1
14	Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer显示文摘	Domingo E Church DN Sieber O	2013	J Clin Oncol2013，31，34：	1
15	Clinical review-small cell carcinoma of the bladder显示文摘	Church DN Bahl A	2006	Cancer Treat Rev2006，32，8：	1
16	Survivin in solid tumors:rationale for development of inhibitors显示文摘	Church DN Talbot DC		0，，02：	1
17	Survivin in solid tumors: rationale for development of inhibitors 显示文摘	CHURCH DN DC TALBOT	2012	Curr Oncol Rep2012，14，2：	1
18	Prognostic significance of POLE proofreading mutations in endometrial cancer显示文摘	Church DN Stelloo E Nout RA et aJ	2014	J Natl Cancer Inst2014，107，1：	1
19	Prognostic significance of POLE proofreading mutations in endometrial cancer显示文摘	Church DN Stelloo E Nout RA	2014	J Natl Cancer Inst2014，12，107：	1
20	Extended survival in women with brain metastases from HER2-ovcrexpressing breast cancer显示文摘	Church DN Modgil R Guglani S	2008	Am J Clin Oncol2008，31，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示